228 related articles for article (PubMed ID: 34651663)
21. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
[TBL] [Abstract][Full Text] [Related]
22. Decreased RNA‑binding protein IGF2BP2 downregulates NT5DC2, which suppresses cell proliferation, and induces cell cycle arrest and apoptosis in diffuse large B‑cell lymphoma cells by regulating the p53 signaling pathway.
Cui Y; Wen Y; Lv C; Zhao D; Yang Y; Qiu H; Wang C
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894142
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
[TBL] [Abstract][Full Text] [Related]
24. CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma.
Zhang CZ; Chen SL; Wang CH; He YF; Yang X; Xie D; Yun JP
Cancer Res; 2018 Jan; 78(1):51-63. PubMed ID: 29066512
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.
Tang J; Wang G; Zhang M; Li FY; Sang Y; Wang B; Hu K; Wu Y; Luo R; Liao D; Cao J; Wang X; Wang L; Zhang R; Zhang X; Deng WG; Xie D; Xu RH; Kang T
Oncotarget; 2014 Nov; 5(21):10778-90. PubMed ID: 25360999
[TBL] [Abstract][Full Text] [Related]
27. Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway.
Xu Y; Yao Y; Leng K; Ji D; Qu L; Liu Y; Cui Y
Cell Physiol Biochem; 2018; 51(4):1710-1722. PubMed ID: 30504704
[TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p.
Zhao J; Su L; Jiang J
Med Sci Monit; 2020 Sep; 26():e922810. PubMed ID: 32976381
[TBL] [Abstract][Full Text] [Related]
29. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL.
Chen H; Su Y; Yang L; Xi L; Li X; Lan B; Liu M; Xuan C
J Cell Physiol; 2023 Nov; 238(11):2710-2723. PubMed ID: 37733753
[TBL] [Abstract][Full Text] [Related]
30. Insulin-Like Growth Factor-1 Modulates Polycomb Cbx8 Expression and Inhibits Colon Cancer Cell Apoptosis.
Yang S; Liu W; Li M; Wen J; Zhu M; Xu S
Cell Biochem Biophys; 2015 Apr; 71(3):1503-7. PubMed ID: 25398592
[TBL] [Abstract][Full Text] [Related]
31. CBX8 promotes tumorigenesis and confers radioresistance in esophageal squamous cell carcinoma cells through targeting APAF1.
Zhang Y; Chen H; Zhu H; Sun X
Gene; 2019 Aug; 711():143949. PubMed ID: 31255735
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
Yang JM; Jang JY; Jeon YK; Paik JH
J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
[TBL] [Abstract][Full Text] [Related]
33. PIM1-catalyzed CBX8 phosphorylation promotes the oncogene-induced senescence of human diploid fibroblast.
Zhan X; Yang J; Mao Z; Yu W
Biochem Biophys Res Commun; 2018 Jun; 501(3):779-785. PubMed ID: 29763603
[TBL] [Abstract][Full Text] [Related]
34. [Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance].
Song GQ; Gu L; He BS; Pan YQ; Wang SK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1603-9. PubMed ID: 25543482
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of miR-518a-5p-CCR6 feedback loop promotes both proliferation and invasion in diffuse large B cell lymphoma.
Huang Q; Zhang F; Fu H; Shen J
Epigenetics; 2021 Jan; 16(1):28-44. PubMed ID: 32600091
[TBL] [Abstract][Full Text] [Related]
36. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198.
Wang R; Shen J; Wang Q; Zhang M
Biomed Pharmacother; 2018 Dec; 108():43-49. PubMed ID: 30216798
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
Su Y; Sun B; Lin X; Zhao X; Ji W; He M; Qian H; Song X; Yang J; Wang J; Chen J
Oncotarget; 2016 Aug; 7(31):49143-49155. PubMed ID: 27172795
[TBL] [Abstract][Full Text] [Related]
38. Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma.
Yan S; Shang Q; Zhu H; Chen K; Li X; Gao H; Liu B; Feng M; Gao L
Evid Based Complement Alternat Med; 2022; 2022():4290994. PubMed ID: 35873635
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.
Gu L; Song G; Chen L; Nie Z; He B; Pan Y; Xu Y; Li R; Gao T; Cho WC; Wang S
Acta Haematol; 2013; 130(2):87-94. PubMed ID: 23548551
[TBL] [Abstract][Full Text] [Related]
40. Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma.
Song J; Shao Q; Li C; Liu H; Li J; Wang Y; Song W; Li L; Wang G; Shao Z; Fu R
Medicine (Baltimore); 2017 Sep; 96(39):e7952. PubMed ID: 28953617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
